Cryomass Technologies

Cryomass Technologies EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cryomass Technologies (CRYM) as of Nov 19, 2026 is -5.61 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -10.15 M USD — a change of -44.74% (higher).

EBITDA

-5.61 MUSD

YoY

-44.74%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cryomass Technologies is 2023 -5.61 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cryomass Technologies was 2022 -10.15 M USD. It decreases by -44.74% higher compared to the previous year.

The Cryomass Technologies EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2016
-50,000.00 USD
Jan 1, 2017
-51,874.00 USD
Jan 1, 2018
-336,626.00 USD
Jan 1, 2019
-3.02 M USD
Jan 1, 2020
-6.53 M USD
Jan 1, 2021
-7.95 M USD
Jan 1, 2022
-10.15 M USD
Jan 1, 2023
-5.61 M USD
The Cryomass Technologies EBITDA history
YEAREBITDAYoY
-5.61 MUSD-44.74%
-10.15 MUSD+27.67%
-7.95 MUSD+21.68%
-6.53 MUSD+116.35%
-3.02 MUSD+797.29%
-336,626.00USD+548.93%
-51,874.00USD+3.75%
-50,000.00USD+150.00%
-20,000.00USD-33.33%
-30,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cryomass Technologies is -5.61 M USD in 2023.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cryomass Technologies changed from -10.15 M USD to -5.61 M USD, representing a -44.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Cryomass Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cryomass Technologies

All Key Metrics — Cryomass Technologies